Onward’s Arc-Ex earned FDA 510(k) clearance for use at home, according to a Nov. 17 news release. The device is cleared for “use in conjunction with functional task practice in the clinic and ...

Kelly Carnahan is no stranger to medical procedures. For the past three years, 52-old Kelly Carnahan has been dealing with chronic back pain and has tried just about everything to get relief from her ...

On May 16, 2023, the U.S. Food and Drug Administration (FDA) approved spinal cord stimulation (SCS) devices from the pharmaceutical company Abbott to treat chronic back pain in people who have not had ...

University Orthopedics’ East Bay Surgery Center in East Providence, R.I., has become the first site in the state to implant a closed-loop spinal cord stimulator. Shiqiang “Chris” Tian, MD, an ...

Christopher Maher holds a research fellowship funded by the National Health and Medical Research Council. Caitlin Jones does not work for, consult, own shares in or receive funding from any company or ...

Abbott is putting the old adage that “good things come in threes” to the test, with its fourth FDA approval in less than a year for its spinal cord stimulation (SCS) systems. The latest regulatory nod ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

Spinal cord stimulators are electrical devices that are surgically implanted in the body to treat long-term pain. They have a battery pack and leads that deliver electrical impulses directly to the ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Independent studies suggested that spinal cord stimulation ...

Ian Harris receives funding from research organisations unrelated to spinal cord stimulators. He was interviewed for the Four Corners episode referred to. Adrian C Traeger receives research funding ...